Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03054363 |
|---|---|
| Brief Title: | Tucatinib, Palbociclib and Letrozole in Metastatic Hormone Receptor Positive and HER2-positive Breast Cancer |
| First Submitted : | February 7, 2017 |
| First Submitted that Met QC Criteria : | February 10, 2017 |
| First Posted : | February 15, 2017 |
| Last Update Submitted that Met QC Criteria : | May 1, 2020 |
| Last Update Posted : | May 4, 2020 |